Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.coviro.2021.03.009 http://scihub22266oqcxt.onion/10.1016/j.coviro.2021.03.009 33906125!8023231!33906125     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33906125&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\33906125.jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Curr+Opin+Virol 2021 ; 48 (�): 73-81 Nephropedia Template TP {{tp|p=33906125|t=2021. Animal models for SARS-CoV-2 |pdf=|usr=}}{{33906125}} gab.com Text Animal models for SARS-CoV-2 JO: Curr Opin Virol http://www.kidney.de/pget.php?&tw=1&pmid=33906125 #FOAvip Since its first detection in December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide, resulting in over 79.2 million documented cases in one year. Lack of pre-existing immunity against this newly emerging virus has pushed the urgent development of anti-viral therapeutics and vaccines to reduce the spread of the virus and alleviate disease. Appropriate animal models recapitulating the pathogenesis of and host responses to SARS-CoV-2 infection in humans have and will continue to accelerate this development process. Several animal models including mice, hamsters, ferrets, and non-human primates have been evaluated and actively applied in preclinical studies. However, since each animal model has unique features, it is necessary to weigh the strengths and weaknesses of each according to the goals of the study. Here, we summarize the key features, strengths and weaknesses of animal models for SARS-CoV-2, focusing on their application in anti-viral therapeutic and vaccine development. Twit Text FOAVip Animal models for SARS-CoV-2 ????Curr Opin Virol http://www.kidney.de/pget.php?&tw=1&pmid=33906125 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33906125 #FOAvip English Wikipedia <ref>{{Cite pmid|33906125}}</ref> Animal models for SARS-CoV-2 #MMPMID33906125 Lee CY; Lowen AC Curr Opin Virol 2021[Jun]; 48 (�): 73-81 PMID33906125show ga Since its first detection in December 2019, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has rapidly spread worldwide, resulting in over 79.2 million documented cases in one year. Lack of pre-existing immunity against this newly emerging virus has pushed the urgent development of anti-viral therapeutics and vaccines to reduce the spread of the virus and alleviate disease. Appropriate animal models recapitulating the pathogenesis of and host responses to SARS-CoV-2 infection in humans have and will continue to accelerate this development process. Several animal models including mice, hamsters, ferrets, and non-human primates have been evaluated and actively applied in preclinical studies. However, since each animal model has unique features, it is necessary to weigh the strengths and weaknesses of each according to the goals of the study. Here, we summarize the key features, strengths and weaknesses of animal models for SARS-CoV-2, focusing on their application in anti-viral therapeutic and vaccine development. |*COVID-19 Drug Treatment[MESH] |*COVID-19/prevention & control[MESH] |*Disease Models, Animal[MESH] |Animals[MESH] |Antiviral Agents/*therapeutic use[MESH] |COVID-19 Vaccines/*administration & dosage[MESH]Animal models for SARS-CoV-2 (epmc).pdf DeepDyve Pubget Overpricing